

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic sister chromatid segregation (GO:0000070) | 7.10183043 |
| 2 | sister chromatid segregation (GO:0000819) | 6.85909038 |
| 3 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 6.65520122 |
| 4 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.71619273 |
| 5 | mitotic chromosome condensation (GO:0007076) | 5.65579858 |
| 6 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 5.46333573 |
| 7 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 5.46333573 |
| 8 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 5.46333573 |
| 9 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.26143357 |
| 10 | protein localization to chromosome, centromeric region (GO:0071459) | 5.17399422 |
| 11 | protein localization to kinetochore (GO:0034501) | 5.13388319 |
| 12 | positive regulation of chromosome segregation (GO:0051984) | 5.06362096 |
| 13 | DNA unwinding involved in DNA replication (GO:0006268) | 4.58890652 |
| 14 | mitotic metaphase plate congression (GO:0007080) | 4.58845817 |
| 15 | kinetochore organization (GO:0051383) | 4.46842115 |
| 16 | regulation of exit from mitosis (GO:0007096) | 4.46431224 |
| 17 | regulation of spindle organization (GO:0090224) | 4.45025396 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33999095 |
| 19 | regulation of mitotic spindle organization (GO:0060236) | 4.32469452 |
| 20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.29394552 |
| 21 | establishment of chromosome localization (GO:0051303) | 4.24488507 |
| 22 | protein localization to chromosome (GO:0034502) | 4.15876285 |
| 23 | metaphase plate congression (GO:0051310) | 4.11774335 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.09378095 |
| 25 | negative regulation of cell killing (GO:0031342) | 4.09378095 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08676911 |
| 27 | microtubule depolymerization (GO:0007019) | 4.05297659 |
| 28 | regulation of chromosome segregation (GO:0051983) | 4.05114276 |
| 29 | thymic T cell selection (GO:0045061) | 4.04635718 |
| 30 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.01121744 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.96850593 |
| 32 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.80975706 |
| 33 | leukocyte aggregation (GO:0070486) | 3.79124851 |
| 34 | chromosome segregation (GO:0007059) | 3.76720171 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75694013 |
| 36 | mitotic nuclear envelope disassembly (GO:0007077) | 3.71985857 |
| 37 | meiotic chromosome segregation (GO:0045132) | 3.71099258 |
| 38 | kinetochore assembly (GO:0051382) | 3.71066361 |
| 39 | DNA topological change (GO:0006265) | 3.66510351 |
| 40 | spindle assembly checkpoint (GO:0071173) | 3.62015420 |
| 41 | chromosome condensation (GO:0030261) | 3.61746812 |
| 42 | negative regulation of chromosome segregation (GO:0051985) | 3.61481394 |
| 43 | spindle checkpoint (GO:0031577) | 3.59576076 |
| 44 | establishment of mitotic spindle localization (GO:0040001) | 3.57541606 |
| 45 | erythrocyte maturation (GO:0043249) | 3.56944520 |
| 46 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.55530759 |
| 47 | regulation of histone H3-K27 methylation (GO:0061085) | 3.55068901 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.54666936 |
| 49 | mitotic spindle assembly checkpoint (GO:0007094) | 3.54242831 |
| 50 | activation of Rac GTPase activity (GO:0032863) | 3.53441062 |
| 51 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.51302709 |
| 52 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.51220260 |
| 53 | negative regulation of sister chromatid segregation (GO:0033046) | 3.51220260 |
| 54 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.51220260 |
| 55 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.51220260 |
| 56 | negative T cell selection (GO:0043383) | 3.50914160 |
| 57 | response to laminar fluid shear stress (GO:0034616) | 3.45826160 |
| 58 | membrane disassembly (GO:0030397) | 3.44574394 |
| 59 | nuclear envelope disassembly (GO:0051081) | 3.44574394 |
| 60 | regulation of sister chromatid segregation (GO:0033045) | 3.43830371 |
| 61 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.43830371 |
| 62 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.43830371 |
| 63 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.42706563 |
| 64 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.40098260 |
| 65 | mitotic spindle checkpoint (GO:0071174) | 3.39835260 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.35353301 |
| 67 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.34653150 |
| 68 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.34468210 |
| 69 | mitotic cytokinesis (GO:0000281) | 3.32985751 |
| 70 | CENP-A containing nucleosome assembly (GO:0034080) | 3.31191731 |
| 71 | regulation of sister chromatid cohesion (GO:0007063) | 3.29695481 |
| 72 | T cell selection (GO:0045058) | 3.29608871 |
| 73 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.25171166 |
| 74 | negative regulation of histone methylation (GO:0031061) | 3.23633083 |
| 75 | DNA replication-independent nucleosome organization (GO:0034724) | 3.19440947 |
| 76 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.19440947 |
| 77 | DNA strand elongation (GO:0022616) | 3.16844611 |
| 78 | regulation of extracellular matrix disassembly (GO:0010715) | 3.15786873 |
| 79 | signal complex assembly (GO:0007172) | 3.15693003 |
| 80 | regulation of early endosome to late endosome transport (GO:2000641) | 3.14668427 |
| 81 | mitotic recombination (GO:0006312) | 3.14304138 |
| 82 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.13745212 |
| 83 | chromatin remodeling at centromere (GO:0031055) | 3.13627460 |
| 84 | apoptotic process involved in morphogenesis (GO:0060561) | 3.13392889 |
| 85 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13191853 |
| 86 | COPI coating of Golgi vesicle (GO:0048205) | 3.13006618 |
| 87 | Golgi transport vesicle coating (GO:0048200) | 3.13006618 |
| 88 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.12533261 |
| 89 | negative regulation of phagocytosis (GO:0050765) | 3.10782721 |
| 90 | heme biosynthetic process (GO:0006783) | 3.09257006 |
| 91 | chromatin assembly or disassembly (GO:0006333) | 3.09037308 |
| 92 | regulation of defense response to virus by virus (GO:0050690) | 3.08964064 |
| 93 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.07149867 |
| 94 | ATP-dependent chromatin remodeling (GO:0043044) | 3.01984455 |
| 95 | V(D)J recombination (GO:0033151) | 3.01581609 |
| 96 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.98565740 |
| 97 | regulation of histone H3-K9 methylation (GO:0051570) | 2.97846168 |
| 98 | positive T cell selection (GO:0043368) | 2.97180875 |
| 99 | DNA packaging (GO:0006323) | 2.97100933 |
| 100 | negative regulation of cell size (GO:0045792) | 2.97066049 |
| 101 | DNA replication initiation (GO:0006270) | 2.96010961 |
| 102 | negative regulation of RNA splicing (GO:0033119) | 2.92857642 |
| 103 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.92799887 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 2.91554308 |
| 105 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91132482 |
| 106 | regulation of T cell tolerance induction (GO:0002664) | 2.88984194 |
| 107 | regulation of centrosome cycle (GO:0046605) | 2.85786175 |
| 108 | telomere maintenance via recombination (GO:0000722) | 2.85160245 |
| 109 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.84640846 |
| 110 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84492267 |
| 111 | protein localization to endosome (GO:0036010) | 2.83921276 |
| 112 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.82671094 |
| 113 | modulation by virus of host process (GO:0019054) | 2.82307948 |
| 114 | mitotic sister chromatid cohesion (GO:0007064) | 2.80752866 |
| 115 | modulation by symbiont of host cellular process (GO:0044068) | 2.80069670 |
| 116 | histone-serine phosphorylation (GO:0035404) | 2.79093067 |
| 117 | nuclear envelope organization (GO:0006998) | 2.78389715 |
| 118 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76012553 |
| 119 | focal adhesion assembly (GO:0048041) | 2.75240320 |
| 120 | cell-substrate adherens junction assembly (GO:0007045) | 2.75240320 |
| 121 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.73660617 |
| 122 | tetrapyrrole biosynthetic process (GO:0033014) | 2.73623028 |
| 123 | cytokinetic process (GO:0032506) | 2.71713285 |
| 124 | DNA replication checkpoint (GO:0000076) | 2.71538208 |
| 125 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.71189581 |
| 126 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.71189581 |
| 127 | histone exchange (GO:0043486) | 2.69706879 |
| 128 | B cell receptor signaling pathway (GO:0050853) | 2.68739296 |
| 129 | regulation of chromatin binding (GO:0035561) | 2.68631947 |
| 130 | DNA conformation change (GO:0071103) | 2.66720705 |
| 131 | cellular response to interleukin-4 (GO:0071353) | 2.66622476 |
| 132 | DNA geometric change (GO:0032392) | 2.66026375 |
| 133 | protein-DNA complex disassembly (GO:0032986) | 2.65397474 |
| 134 | nucleosome disassembly (GO:0006337) | 2.65397474 |
| 135 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.64961213 |
| 136 | positive thymic T cell selection (GO:0045059) | 2.64585866 |
| 137 | chromatin assembly (GO:0031497) | 2.64453799 |
| 138 | DNA duplex unwinding (GO:0032508) | 2.64285406 |
| 139 | erythrocyte development (GO:0048821) | 2.64100065 |
| 140 | * mitotic cell cycle (GO:0000278) | 2.63865615 |
| 141 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.63440592 |
| 142 | negative regulation of chromosome organization (GO:2001251) | 2.62413428 |
| 143 | mannose metabolic process (GO:0006013) | 2.60193886 |
| 144 | adherens junction assembly (GO:0034333) | 2.59590521 |
| 145 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.59212069 |
| 146 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.57636741 |
| 147 | cellular response to virus (GO:0098586) | 2.56808462 |
| 148 | pentose-phosphate shunt (GO:0006098) | 2.51066864 |
| 149 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.49268332 |
| 150 | barbed-end actin filament capping (GO:0051016) | 2.49071615 |
| 151 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.45548611 |
| 152 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43841154 |
| 153 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43728053 |
| 154 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.42674467 |
| 155 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.42030782 |
| 156 | response to interleukin-4 (GO:0070670) | 2.37825210 |
| 157 | response to interleukin-15 (GO:0070672) | 2.37206438 |
| 158 | negative regulation of viral release from host cell (GO:1902187) | 2.37155388 |
| 159 | positive regulation of histone deacetylation (GO:0031065) | 2.36037573 |
| 160 | maternal placenta development (GO:0001893) | 2.35931053 |
| 161 | embryonic process involved in female pregnancy (GO:0060136) | 2.34488008 |
| 162 | modulation by symbiont of host immune response (GO:0052553) | 2.34275663 |
| 163 | positive regulation by symbiont of host defense response (GO:0052509) | 2.34275663 |
| 164 | modulation by symbiont of host defense response (GO:0052031) | 2.34275663 |
| 165 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.34275663 |
| 166 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.34275663 |
| 167 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.34275663 |
| 168 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.32349294 |
| 169 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.31694072 |
| 170 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31633073 |
| 171 | modulation by virus of host morphology or physiology (GO:0019048) | 2.31127561 |
| 172 | negative regulation of necroptotic process (GO:0060546) | 2.31005113 |
| 173 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.29729745 |
| 174 | tolerance induction (GO:0002507) | 2.29177367 |
| 175 | T cell migration (GO:0072678) | 2.28172810 |
| 176 | cell-substrate junction assembly (GO:0007044) | 2.27221577 |
| 177 | response to muramyl dipeptide (GO:0032495) | 2.26656625 |
| 178 | regulation of necroptotic process (GO:0060544) | 2.25928165 |
| 179 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.24631309 |
| 180 | glucose 6-phosphate metabolic process (GO:0051156) | 2.24450108 |
| 181 | protein retention in ER lumen (GO:0006621) | 2.20164461 |
| 182 | activation of JUN kinase activity (GO:0007257) | 2.19453867 |
| 183 | hepatocyte apoptotic process (GO:0097284) | 2.18507552 |
| 184 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.13994297 |
| 185 | stress fiber assembly (GO:0043149) | 2.13621964 |
| 186 | regulation of extracellular matrix organization (GO:1903053) | 2.12725200 |
| 187 | histone phosphorylation (GO:0016572) | 2.12637734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 9.33926043 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.10327379 |
| 3 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 4.57954149 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.21822546 |
| 5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.56946966 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.29376955 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98287496 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.61973174 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48758820 |
| 10 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.41072962 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25474910 |
| 12 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.13630402 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.10599603 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.06456929 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.98416794 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98187764 |
| 17 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.95844804 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95810319 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95069507 |
| 20 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93163462 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77169981 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.74731795 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73730248 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71437273 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70459402 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64302032 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.63494184 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63022044 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.61121238 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60785894 |
| 31 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60478997 |
| 32 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.60053324 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57940025 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54903535 |
| 35 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.52528720 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50568317 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.49670506 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49287081 |
| 39 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46887073 |
| 40 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.43977966 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40606791 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39142763 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37566224 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37405412 |
| 45 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36204524 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36092061 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35551710 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33956122 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33441876 |
| 50 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.33093583 |
| 51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.32955900 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.32515833 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32279068 |
| 54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.31486005 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30734692 |
| 56 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30601296 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30497412 |
| 58 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.30100496 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.29824516 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29422947 |
| 61 | * P68_20966046_ChIP-Seq_HELA_Human | 1.29279200 |
| 62 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.28936243 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26875038 |
| 64 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.26034052 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25926158 |
| 66 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24846260 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24678881 |
| 68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23218264 |
| 69 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.22716363 |
| 70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22676817 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22067123 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21879407 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21587766 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21394261 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21214545 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19889368 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19576996 |
| 78 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.19231351 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18048769 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16924047 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16751811 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16238851 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16047625 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15667177 |
| 85 | * MAF_26560356_Chip-Seq_TH2_Human | 1.15642761 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15269167 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15197514 |
| 88 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14894087 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14054690 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14009625 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13738668 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13698974 |
| 93 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13556953 |
| 94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13302750 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12882457 |
| 96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12561350 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08549714 |
| 98 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08403824 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07499162 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07103347 |
| 101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06085797 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05698227 |
| 103 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.05542927 |
| 104 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05536880 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05084470 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03774353 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03075279 |
| 108 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02261886 |
| 109 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02128813 |
| 110 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01765289 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00529665 |
| 112 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00079873 |
| 113 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99850308 |
| 114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99756570 |
| 115 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99328040 |
| 116 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98739130 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98502338 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98167364 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97384034 |
| 120 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97138552 |
| 121 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96112949 |
| 122 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.96043977 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96038788 |
| 124 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.95831836 |
| 125 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95736627 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95004910 |
| 127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94813795 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94572926 |
| 129 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93537898 |
| 130 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93242584 |
| 131 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90754221 |
| 132 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89435661 |
| 133 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88420255 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88125485 |
| 135 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87660498 |
| 136 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.86476954 |
| 137 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86169447 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85933095 |
| 139 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.84794053 |
| 140 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83965773 |
| 141 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82599344 |
| 142 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82059766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003111_abnormal_nucleus_morphology | 4.61722935 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.02073814 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.76461892 |
| 4 | MP0003077_abnormal_cell_cycle | 3.72464976 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 3.50983388 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 2.86819090 |
| 7 | MP0004147_increased_porphyrin_level | 2.83874478 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.71495997 |
| 9 | MP0005451_abnormal_body_composition | 2.55281096 |
| 10 | MP0008260_abnormal_autophagy | 2.55248332 |
| 11 | MP0000685_abnormal_immune_system | 2.43963401 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.24190387 |
| 13 | MP0004808_abnormal_hematopoietic_stem | 2.22067439 |
| 14 | MP0005076_abnormal_cell_differentiation | 2.20515130 |
| 15 | MP0002398_abnormal_bone_marrow | 2.19141831 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.08363826 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.07565340 |
| 18 | MP0004381_abnormal_hair_follicle | 2.01318892 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.01205448 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.99910955 |
| 21 | MP0008057_abnormal_DNA_replication | 1.99880266 |
| 22 | MP0005671_abnormal_response_to | 1.99863376 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.99863074 |
| 24 | MP0000703_abnormal_thymus_morphology | 1.96872122 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.94725751 |
| 26 | MP0000350_abnormal_cell_proliferation | 1.94278881 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.93118495 |
| 28 | MP0001800_abnormal_humoral_immune | 1.90889596 |
| 29 | MP0008007_abnormal_cellular_replicative | 1.89984651 |
| 30 | MP0002722_abnormal_immune_system | 1.85799805 |
| 31 | MP0001730_embryonic_growth_arrest | 1.84856731 |
| 32 | MP0001348_abnormal_lacrimal_gland | 1.83306580 |
| 33 | MP0000490_abnormal_crypts_of | 1.82061885 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.80868257 |
| 35 | MP0010307_abnormal_tumor_latency | 1.80336221 |
| 36 | MP0008058_abnormal_DNA_repair | 1.79855794 |
| 37 | MP0009278_abnormal_bone_marrow | 1.71139921 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.70736472 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.64820987 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.64820987 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.62952822 |
| 42 | MP0003091_abnormal_cell_migration | 1.62105232 |
| 43 | MP0006054_spinal_hemorrhage | 1.59513625 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.57457016 |
| 45 | MP0002429_abnormal_blood_cell | 1.56642687 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.55567303 |
| 47 | MP0004858_abnormal_nervous_system | 1.55425362 |
| 48 | MP0008932_abnormal_embryonic_tissue | 1.54884131 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.53727397 |
| 50 | MP0000716_abnormal_immune_system | 1.53697694 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.50071653 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.49688280 |
| 53 | MP0001819_abnormal_immune_cell | 1.45898572 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.45082529 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.39630249 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.38153865 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.34615787 |
| 58 | MP0003123_paternal_imprinting | 1.34543347 |
| 59 | MP0005387_immune_system_phenotype | 1.34494671 |
| 60 | MP0001790_abnormal_immune_system | 1.34494671 |
| 61 | MP0002796_impaired_skin_barrier | 1.34470475 |
| 62 | MP0003303_peritoneal_inflammation | 1.33752763 |
| 63 | MP0005409_darkened_coat_color | 1.29292000 |
| 64 | MP0000678_abnormal_parathyroid_gland | 1.29134157 |
| 65 | MP0000313_abnormal_cell_death | 1.28865525 |
| 66 | MP0000733_abnormal_muscle_development | 1.25105832 |
| 67 | MP0002080_prenatal_lethality | 1.24706664 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.24626354 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.24207884 |
| 70 | MP0001697_abnormal_embryo_size | 1.22876383 |
| 71 | MP0002060_abnormal_skin_morphology | 1.21512825 |
| 72 | MP0005380_embryogenesis_phenotype | 1.20767041 |
| 73 | MP0001672_abnormal_embryogenesis/_devel | 1.20767041 |
| 74 | MP0002723_abnormal_immune_serum | 1.20640027 |
| 75 | MP0001873_stomach_inflammation | 1.19662379 |
| 76 | MP0003866_abnormal_defecation | 1.19591117 |
| 77 | MP0001958_emphysema | 1.19113978 |
| 78 | MP0002085_abnormal_embryonic_tissue | 1.17900774 |
| 79 | MP0009840_abnormal_foam_cell | 1.13930718 |
| 80 | MP0002419_abnormal_innate_immunity | 1.13826092 |
| 81 | MP0002653_abnormal_ependyma_morphology | 1.13597568 |
| 82 | MP0002405_respiratory_system_inflammati | 1.13195039 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.12717364 |
| 84 | MP0005623_abnormal_meninges_morphology | 1.11749902 |
| 85 | MP0005257_abnormal_intraocular_pressure | 1.09575756 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.09156672 |
| 87 | MP0004233_abnormal_muscle_weight | 1.08714215 |
| 88 | MP0003984_embryonic_growth_retardation | 1.07846426 |
| 89 | MP0005464_abnormal_platelet_physiology | 1.06749835 |
| 90 | MP0002088_abnormal_embryonic_growth/wei | 1.06403189 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 1.05524276 |
| 92 | MP0002166_altered_tumor_susceptibility | 1.05093208 |
| 93 | MP0002249_abnormal_larynx_morphology | 1.04824461 |
| 94 | MP0001851_eye_inflammation | 1.04058211 |
| 95 | MP0001853_heart_inflammation | 1.01934212 |
| 96 | MP0003436_decreased_susceptibility_to | 1.01601716 |
| 97 | MP0001533_abnormal_skeleton_physiology | 1.00855691 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.98814841 |
| 99 | MP0003787_abnormal_imprinting | 0.97472019 |
| 100 | MP0002084_abnormal_developmental_patter | 0.96986338 |
| 101 | MP0003279_aneurysm | 0.96433305 |
| 102 | MP0000858_altered_metastatic_potential | 0.96401249 |
| 103 | MP0004947_skin_inflammation | 0.95331080 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 0.92970113 |
| 105 | MP0005501_abnormal_skin_physiology | 0.91879444 |
| 106 | MP0005023_abnormal_wound_healing | 0.90748799 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.89576526 |
| 108 | MP0003121_genomic_imprinting | 0.86189076 |
| 109 | MP0002751_abnormal_autonomic_nervous | 0.86121348 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.86051262 |
| 111 | MP0002009_preneoplasia | 0.85617228 |
| 112 | MP0003890_abnormal_embryonic-extraembry | 0.85603952 |
| 113 | MP0004133_heterotaxia | 0.85300456 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.84837930 |
| 115 | MP0002089_abnormal_postnatal_growth/wei | 0.84709728 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.84158480 |
| 117 | MP0005621_abnormal_cell_physiology | 0.83956332 |
| 118 | MP0001243_abnormal_dermal_layer | 0.82832769 |
| 119 | MP0008789_abnormal_olfactory_epithelium | 0.82397868 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.82019290 |
| 121 | MP0003448_altered_tumor_morphology | 0.81420031 |
| 122 | MP0003115_abnormal_respiratory_system | 0.81254112 |
| 123 | MP0003786_premature_aging | 0.80226017 |
| 124 | MP0005025_abnormal_response_to | 0.79824311 |
| 125 | MP0008770_decreased_survivor_rate | 0.79265924 |
| 126 | MP0002933_joint_inflammation | 0.78389765 |
| 127 | MP0002282_abnormal_trachea_morphology | 0.77920239 |
| 128 | MP0002006_tumorigenesis | 0.76738415 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.74674773 |
| 130 | MP0008877_abnormal_DNA_methylation | 0.74047991 |
| 131 | MP0001849_ear_inflammation | 0.73225977 |
| 132 | MP0004264_abnormal_extraembryonic_tissu | 0.72722411 |
| 133 | MP0003315_abnormal_perineum_morphology | 0.71844684 |
| 134 | MP0000566_synostosis | 0.71826030 |
| 135 | MP0009931_abnormal_skin_appearance | 0.71811501 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.70568901 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.70479024 |
| 138 | MP0005384_cellular_phenotype | 0.69984215 |
| 139 | MP0002932_abnormal_joint_morphology | 0.68892735 |
| 140 | MP0000477_abnormal_intestine_morphology | 0.65581644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.05930933 |
| 2 | Poikilocytosis (HP:0004447) | 4.74933125 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 3.50373774 |
| 4 | Verrucae (HP:0200043) | 3.50275341 |
| 5 | Papilloma (HP:0012740) | 3.50275341 |
| 6 | Cellulitis (HP:0100658) | 3.34113757 |
| 7 | Agammaglobulinemia (HP:0004432) | 3.31331816 |
| 8 | Reticulocytosis (HP:0001923) | 3.23278189 |
| 9 | Broad face (HP:0000283) | 3.20232403 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.16560705 |
| 11 | Hypochromic anemia (HP:0001931) | 3.08008782 |
| 12 | Acanthocytosis (HP:0001927) | 3.07416794 |
| 13 | Abnormality of the fingertips (HP:0001211) | 3.03487122 |
| 14 | Abnormality of the intervertebral disk (HP:0005108) | 2.95551572 |
| 15 | Protrusio acetabuli (HP:0003179) | 2.92555440 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.87748488 |
| 17 | Combined immunodeficiency (HP:0005387) | 2.85442433 |
| 18 | Abnormality of reticulocytes (HP:0004312) | 2.84556610 |
| 19 | Vertebral compression fractures (HP:0002953) | 2.78299913 |
| 20 | Premature rupture of membranes (HP:0001788) | 2.76070311 |
| 21 | Basal cell carcinoma (HP:0002671) | 2.71461113 |
| 22 | Obstructive sleep apnea (HP:0002870) | 2.70471116 |
| 23 | Recurrent bronchitis (HP:0002837) | 2.67650714 |
| 24 | Increased nuchal translucency (HP:0010880) | 2.67117286 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 2.63589766 |
| 26 | Volvulus (HP:0002580) | 2.58778906 |
| 27 | Patellar aplasia (HP:0006443) | 2.58758446 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.57035998 |
| 29 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.56292854 |
| 30 | T lymphocytopenia (HP:0005403) | 2.55541067 |
| 31 | Recurrent viral infections (HP:0004429) | 2.53075229 |
| 32 | Short middle phalanx of the 5th finger (HP:0004220) | 2.51087142 |
| 33 | Insomnia (HP:0100785) | 2.49405386 |
| 34 | B lymphocytopenia (HP:0010976) | 2.48063452 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.48063452 |
| 36 | Thyroiditis (HP:0100646) | 2.45995801 |
| 37 | Increased connective tissue (HP:0009025) | 2.39844787 |
| 38 | Dislocated radial head (HP:0003083) | 2.39650891 |
| 39 | Abnormality of chromosome segregation (HP:0002916) | 2.39562883 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.38595147 |
| 41 | IgM deficiency (HP:0002850) | 2.36434861 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.35226653 |
| 43 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.35129266 |
| 44 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.31743134 |
| 45 | Mitral regurgitation (HP:0001653) | 2.31203894 |
| 46 | Severe combined immunodeficiency (HP:0004430) | 2.29737633 |
| 47 | Long palpebral fissure (HP:0000637) | 2.28772499 |
| 48 | Pustule (HP:0200039) | 2.28175161 |
| 49 | Chromsome breakage (HP:0040012) | 2.27841664 |
| 50 | Abnormality of the radial head (HP:0003995) | 2.25661139 |
| 51 | Micronodular cirrhosis (HP:0001413) | 2.25433404 |
| 52 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.25279575 |
| 53 | Short 4th metacarpal (HP:0010044) | 2.25279575 |
| 54 | Ulnar bowing (HP:0003031) | 2.25111704 |
| 55 | Hyperacusis (HP:0010780) | 2.20676353 |
| 56 | Subacute progressive viral hepatitis (HP:0006572) | 2.18936036 |
| 57 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.17833228 |
| 58 | Disproportionate tall stature (HP:0001519) | 2.17814066 |
| 59 | Ankle contracture (HP:0006466) | 2.17110039 |
| 60 | Increased IgE level (HP:0003212) | 2.16803982 |
| 61 | Achilles tendon contracture (HP:0001771) | 2.15807127 |
| 62 | Reticulocytopenia (HP:0001896) | 2.15718246 |
| 63 | Cafe-au-lait spot (HP:0000957) | 2.15077376 |
| 64 | Chronic otitis media (HP:0000389) | 2.13323164 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.12369267 |
| 66 | Small epiphyses (HP:0010585) | 2.12273574 |
| 67 | Thin bony cortex (HP:0002753) | 2.11648332 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.10927268 |
| 69 | Trismus (HP:0000211) | 2.10199638 |
| 70 | Myelodysplasia (HP:0002863) | 2.09657265 |
| 71 | Long eyelashes (HP:0000527) | 2.09387444 |
| 72 | Ectopic kidney (HP:0000086) | 2.09146476 |
| 73 | Fragile skin (HP:0001030) | 2.09128212 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.08381972 |
| 75 | Duodenal stenosis (HP:0100867) | 2.06790030 |
| 76 | Small intestinal stenosis (HP:0012848) | 2.06790030 |
| 77 | Heterotopia (HP:0002282) | 2.05874462 |
| 78 | High pitched voice (HP:0001620) | 2.05633871 |
| 79 | Spinal cord lesions (HP:0100561) | 2.05484719 |
| 80 | Syringomyelia (HP:0003396) | 2.05484719 |
| 81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04744375 |
| 82 | Cervical subluxation (HP:0003308) | 2.01983986 |
| 83 | Slow saccadic eye movements (HP:0000514) | 2.01568163 |
| 84 | Paralysis (HP:0003470) | 2.01449235 |
| 85 | Vertebral arch anomaly (HP:0008438) | 2.01310865 |
| 86 | Ependymoma (HP:0002888) | 2.00654700 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 2.00246496 |
| 88 | Overlapping toe (HP:0001845) | 2.00101271 |
| 89 | Recurrent bacterial skin infections (HP:0005406) | 2.00092725 |
| 90 | Biconcave vertebral bodies (HP:0004586) | 1.99135507 |
| 91 | Meningitis (HP:0001287) | 1.98985642 |
| 92 | Shallow orbits (HP:0000586) | 1.98395807 |
| 93 | Increased density of long bones (HP:0006392) | 1.98151016 |
| 94 | Hypercortisolism (HP:0001578) | 1.97887444 |
| 95 | Colitis (HP:0002583) | 1.97872202 |
| 96 | Asymmetry of the thorax (HP:0001555) | 1.96588801 |
| 97 | Microcytic anemia (HP:0001935) | 1.95752502 |
| 98 | Birth length less than 3rd percentile (HP:0003561) | 1.95611714 |
| 99 | Distal lower limb muscle weakness (HP:0009053) | 1.95605340 |
| 100 | Cutis marmorata (HP:0000965) | 1.94133919 |
| 101 | Lymphoma (HP:0002665) | 1.93824463 |
| 102 | Generalized amyotrophy (HP:0003700) | 1.92951219 |
| 103 | Cutaneous photosensitivity (HP:0000992) | 1.92576037 |
| 104 | Distal upper limb amyotrophy (HP:0007149) | 1.92556324 |
| 105 | Upper limb amyotrophy (HP:0009129) | 1.92556324 |
| 106 | Easy fatigability (HP:0003388) | 1.92066242 |
| 107 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91676520 |
| 108 | Short 5th finger (HP:0009237) | 1.91255267 |
| 109 | Broad palm (HP:0001169) | 1.90429441 |
| 110 | Poikiloderma (HP:0001029) | 1.89080578 |
| 111 | Selective tooth agenesis (HP:0001592) | 1.88819436 |
| 112 | Abnormality of chromosome stability (HP:0003220) | 1.88638546 |
| 113 | Broad distal phalanx of finger (HP:0009836) | 1.88089465 |
| 114 | Recurrent sinusitis (HP:0011108) | 1.87838455 |
| 115 | Viral hepatitis (HP:0006562) | 1.87589282 |
| 116 | Abnormal number of incisors (HP:0011064) | 1.85872857 |
| 117 | Cutaneous melanoma (HP:0012056) | 1.85291464 |
| 118 | Lymphopenia (HP:0001888) | 1.83490976 |
| 119 | Abnormality of the Achilles tendon (HP:0005109) | 1.83292334 |
| 120 | Abnormality of T cells (HP:0002843) | 1.83291645 |
| 121 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.82803102 |
| 122 | Absent epiphyses (HP:0010577) | 1.82803102 |
| 123 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82713814 |
| 124 | Osteolytic defects of the hand bones (HP:0009699) | 1.82713814 |
| 125 | Aneurysm (HP:0002617) | 1.82532604 |
| 126 | Osteomyelitis (HP:0002754) | 1.80684111 |
| 127 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.79761863 |
| 128 | Abnormality of oral frenula (HP:0000190) | 1.79006131 |
| 129 | Petechiae (HP:0000967) | 1.78164396 |
| 130 | Deep palmar crease (HP:0006191) | 1.77936862 |
| 131 | Hyperparathyroidism (HP:0000843) | 1.77605472 |
| 132 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.77230182 |
| 133 | Medulloblastoma (HP:0002885) | 1.75813708 |
| 134 | Diaphragmatic weakness (HP:0009113) | 1.75571407 |
| 135 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.75195385 |
| 136 | Elbow flexion contracture (HP:0002987) | 1.74934252 |
| 137 | Gastrointestinal inflammation (HP:0004386) | 1.74909786 |
| 138 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74200854 |
| 139 | Renal duplication (HP:0000075) | 1.74038222 |
| 140 | 11 pairs of ribs (HP:0000878) | 1.73668795 |
| 141 | Proximal placement of thumb (HP:0009623) | 1.73575485 |
| 142 | Abnormality of the duodenum (HP:0002246) | 1.71383895 |
| 143 | Meckel diverticulum (HP:0002245) | 1.71350009 |
| 144 | IgG deficiency (HP:0004315) | 1.70596153 |
| 145 | Abnormality of the ileum (HP:0001549) | 1.70497817 |
| 146 | Inflammation of the large intestine (HP:0002037) | 1.69925673 |
| 147 | J-shaped sella turcica (HP:0002680) | 1.69765633 |
| 148 | Interstitial pulmonary disease (HP:0006530) | 1.69562824 |
| 149 | Blue sclerae (HP:0000592) | 1.69375290 |
| 150 | Prominent nose (HP:0000448) | 1.69339277 |
| 151 | Recurrent otitis media (HP:0000403) | 1.69247475 |
| 152 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.69222718 |
| 153 | Pallor (HP:0000980) | 1.68807723 |
| 154 | Deviation of the thumb (HP:0009603) | 1.68337547 |
| 155 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.68258810 |
| 156 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.68247748 |
| 157 | Fatigue (HP:0012378) | 1.67886556 |
| 158 | Emphysema (HP:0002097) | 1.67330156 |
| 159 | Entropion (HP:0000621) | 1.66920599 |
| 160 | Short nail (HP:0001799) | 1.66806576 |
| 161 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.64731825 |
| 162 | Gastrointestinal dysmotility (HP:0002579) | 1.64603704 |
| 163 | Arterial tortuosity (HP:0005116) | 1.64599026 |
| 164 | Spinal rigidity (HP:0003306) | 1.64082904 |
| 165 | Growth hormone excess (HP:0000845) | 1.63867243 |
| 166 | Thin ribs (HP:0000883) | 1.63843393 |
| 167 | Pointed chin (HP:0000307) | 1.63588423 |
| 168 | Flat acetabular roof (HP:0003180) | 1.62789650 |
| 169 | Recurrent fungal infections (HP:0002841) | 1.62760921 |
| 170 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.60997917 |
| 171 | Vascular tortuosity (HP:0004948) | 1.60505250 |
| 172 | Abnormality of the thoracic spine (HP:0100711) | 1.60478118 |
| 173 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.59997626 |
| 174 | Premature skin wrinkling (HP:0100678) | 1.59219685 |
| 175 | Abnormality of the humeroradial joint (HP:0100744) | 1.58450149 |
| 176 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.57690014 |
| 177 | Myositis (HP:0100614) | 1.57521423 |
| 178 | Cholecystitis (HP:0001082) | 1.56860639 |
| 179 | Abnormal gallbladder physiology (HP:0012438) | 1.56860639 |
| 180 | Genu recurvatum (HP:0002816) | 1.56807765 |
| 181 | Gingivitis (HP:0000230) | 1.56779018 |
| 182 | Polygenic inheritance (HP:0010982) | 1.55968158 |
| 183 | Supranuclear gaze palsy (HP:0000605) | 1.54514236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.63246907 |
| 2 | MAP3K10 | 4.03378850 |
| 3 | STK10 | 3.88040843 |
| 4 | PRPF4B | 3.66677992 |
| 5 | SMG1 | 3.37123821 |
| 6 | NEK2 | 3.36406270 |
| 7 | CDC7 | 3.28702956 |
| 8 | EEF2K | 3.13393983 |
| 9 | MAP4K1 | 2.99848047 |
| 10 | TRIB3 | 2.89859938 |
| 11 | CDK12 | 2.66771589 |
| 12 | BRSK2 | 2.42026997 |
| 13 | ICK | 2.29250023 |
| 14 | IRAK3 | 2.20882530 |
| 15 | EIF2AK1 | 2.16353680 |
| 16 | GRK6 | 1.99030081 |
| 17 | WEE1 | 1.86129142 |
| 18 | PKN2 | 1.84955581 |
| 19 | AURKB | 1.77487449 |
| 20 | EPHB1 | 1.74968917 |
| 21 | CDK4 | 1.69442476 |
| 22 | PLK1 | 1.65998099 |
| 23 | MST1R | 1.64735504 |
| 24 | UHMK1 | 1.63705617 |
| 25 | TTK | 1.63032764 |
| 26 | MAP3K8 | 1.61805992 |
| 27 | STK4 | 1.55770440 |
| 28 | EPHA2 | 1.55194234 |
| 29 | MAP3K13 | 1.47325761 |
| 30 | TESK1 | 1.46355292 |
| 31 | TLK1 | 1.42817152 |
| 32 | BRD4 | 1.41962149 |
| 33 | RPS6KA4 | 1.36621112 |
| 34 | RPS6KB2 | 1.35012555 |
| 35 | IRAK4 | 1.32732726 |
| 36 | LRRK2 | 1.30217605 |
| 37 | MARK3 | 1.29486594 |
| 38 | CCNB1 | 1.27580701 |
| 39 | SIK2 | 1.27502932 |
| 40 | * BRSK1 | 1.27133554 |
| 41 | RIPK1 | 1.26761082 |
| 42 | TAOK2 | 1.23511596 |
| 43 | CHEK2 | 1.22439239 |
| 44 | DYRK3 | 1.15510685 |
| 45 | SYK | 1.14528342 |
| 46 | ATR | 1.13560537 |
| 47 | ERN1 | 1.13498915 |
| 48 | CDK8 | 1.11473242 |
| 49 | CDK9 | 1.09811044 |
| 50 | MAP3K3 | 1.09622281 |
| 51 | * AURKA | 1.07572393 |
| 52 | PRKD2 | 1.05243443 |
| 53 | CDK6 | 1.03367678 |
| 54 | CLK1 | 1.00701375 |
| 55 | KSR2 | 0.99632498 |
| 56 | RIPK4 | 0.94693778 |
| 57 | TAOK1 | 0.94418976 |
| 58 | PTK2 | 0.92464645 |
| 59 | MARK2 | 0.91686160 |
| 60 | PRKD3 | 0.88646873 |
| 61 | PASK | 0.88500479 |
| 62 | CDK7 | 0.87848798 |
| 63 | PLK3 | 0.87728129 |
| 64 | * CHEK1 | 0.86625871 |
| 65 | DYRK1B | 0.85465035 |
| 66 | TESK2 | 0.84909406 |
| 67 | PIM1 | 0.84089781 |
| 68 | CSK | 0.83788843 |
| 69 | NEK1 | 0.83084612 |
| 70 | BTK | 0.82527700 |
| 71 | MAP3K1 | 0.79739074 |
| 72 | KSR1 | 0.79487520 |
| 73 | JAK3 | 0.78660429 |
| 74 | TNK2 | 0.78179280 |
| 75 | MAP3K11 | 0.77019888 |
| 76 | BRAF | 0.76508739 |
| 77 | * MELK | 0.76457907 |
| 78 | ITK | 0.75094826 |
| 79 | TBK1 | 0.74006080 |
| 80 | CSF1R | 0.73473112 |
| 81 | MAP2K2 | 0.72202141 |
| 82 | IRAK2 | 0.70489249 |
| 83 | LMTK2 | 0.70065078 |
| 84 | BLK | 0.68433774 |
| 85 | NME2 | 0.67974172 |
| 86 | MET | 0.66452110 |
| 87 | CAMKK1 | 0.66423119 |
| 88 | BMX | 0.66377956 |
| 89 | TYRO3 | 0.64839756 |
| 90 | SCYL2 | 0.64254993 |
| 91 | ZAP70 | 0.63821192 |
| 92 | ARAF | 0.62944091 |
| 93 | MOS | 0.62809965 |
| 94 | PDPK1 | 0.62664029 |
| 95 | STK38 | 0.62497908 |
| 96 | LYN | 0.62374537 |
| 97 | CDK2 | 0.60857489 |
| 98 | SIK3 | 0.60626716 |
| 99 | TYK2 | 0.59399600 |
| 100 | STK3 | 0.57800642 |
| 101 | JAK1 | 0.57512712 |
| 102 | MAP3K14 | 0.57026580 |
| 103 | FGFR4 | 0.56041014 |
| 104 | LIMK1 | 0.55809922 |
| 105 | ATM | 0.55506341 |
| 106 | MKNK1 | 0.55505994 |
| 107 | PAK1 | 0.55066041 |
| 108 | * CDK1 | 0.53085000 |
| 109 | MAPKAPK3 | 0.52450885 |
| 110 | TTN | 0.50302126 |
| 111 | TGFBR1 | 0.49666596 |
| 112 | PAK4 | 0.49091876 |
| 113 | SRPK1 | 0.48368931 |
| 114 | LCK | 0.48025971 |
| 115 | PDK1 | 0.46164420 |
| 116 | HCK | 0.44526349 |
| 117 | ILK | 0.44123025 |
| 118 | RPS6KL1 | 0.43840958 |
| 119 | RPS6KC1 | 0.43840958 |
| 120 | TRPM7 | 0.43694482 |
| 121 | * MAPKAPK2 | 0.42276166 |
| 122 | FGFR3 | 0.40554842 |
| 123 | FGFR2 | 0.40214348 |
| 124 | PDGFRB | 0.39654491 |
| 125 | AKT2 | 0.39437254 |
| 126 | CHUK | 0.38553304 |
| 127 | MAP3K7 | 0.38023958 |
| 128 | * MAPK11 | 0.37762037 |
| 129 | RPS6KA2 | 0.37759647 |
| 130 | FES | 0.37487593 |
| 131 | VRK1 | 0.37034849 |
| 132 | * CDC42BPA | 0.36800430 |
| 133 | SIK1 | 0.36439275 |
| 134 | MAP2K3 | 0.35942991 |
| 135 | PTK6 | 0.35076266 |
| 136 | NEK6 | 0.34839686 |
| 137 | IKBKE | 0.34652540 |
| 138 | MAP3K9 | 0.33566441 |
| 139 | HIPK2 | 0.33359004 |
| 140 | MTOR | 0.32834818 |
| 141 | PBK | 0.32146805 |
| 142 | ALK | 0.31295880 |
| 143 | RAF1 | 0.24793782 |
| 144 | PDGFRA | 0.23323090 |
| 145 | KIT | 0.21981616 |
| 146 | PRKCI | 0.21151284 |
| 147 | PRKCQ | 0.21108553 |
| 148 | PRKCH | 0.21044065 |
| 149 | PLK4 | 0.20858741 |
| 150 | RPS6KA5 | 0.20470419 |
| 151 | MKNK2 | 0.20448972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.76272869 |
| 2 | * Cell cycle_Homo sapiens_hsa04110 | 3.39725163 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.19077609 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.83175427 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.66529519 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.46580469 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.09988845 |
| 8 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.98495391 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.97387884 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96953882 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 1.83475695 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77672562 |
| 13 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.76357368 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.75763737 |
| 15 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.73953436 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.73374509 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.68592514 |
| 18 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.65727691 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.57253864 |
| 20 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.53088409 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.51198680 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.46943154 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44867899 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41911525 |
| 25 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.39685243 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38517415 |
| 27 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.38194444 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35748271 |
| 29 | HTLV-I infection_Homo sapiens_hsa05166 | 1.35274454 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34302974 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30321603 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.29983038 |
| 33 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.25026612 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25021865 |
| 35 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.24863188 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23216842 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.21579386 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20524816 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.16254457 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.15933239 |
| 41 | Colorectal cancer_Homo sapiens_hsa05210 | 1.14727238 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11189514 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10019270 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09198126 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08689722 |
| 46 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08219644 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07247149 |
| 48 | Alcoholism_Homo sapiens_hsa05034 | 1.06399606 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 1.03166961 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.02445567 |
| 51 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.02388202 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.01540083 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 1.00589609 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00007030 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.98784986 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98420373 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 0.97920290 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97884759 |
| 59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97662720 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94182809 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92248939 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92103864 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90653903 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90290035 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88946319 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.88603060 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88547073 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.87190252 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87123470 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.87056499 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86905855 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86305308 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85516962 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84419082 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84194517 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.83302190 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83282630 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82035515 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.79305753 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79106166 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.77131983 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75759931 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73915608 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73686595 |
| 85 | RNA polymerase_Homo sapiens_hsa03020 | 0.73001939 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72475750 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70331377 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70033127 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.68994148 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67243363 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66825585 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66672124 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65479261 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63824464 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63344473 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62286567 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61054024 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58232744 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58087099 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58046894 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.57751566 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.57444761 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.57328967 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.57261383 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56604136 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56463982 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53145711 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52765265 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51016847 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50059528 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49620608 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49155043 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47144349 |
| 114 | Proteasome_Homo sapiens_hsa03050 | 0.46965847 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46029441 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45735436 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.45382566 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44933952 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43709268 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43534533 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43040701 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.42921408 |
| 123 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41551095 |
| 124 | Malaria_Homo sapiens_hsa05144 | 0.40559355 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38708231 |
| 126 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38487536 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38038907 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36208593 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35614399 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35584679 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35318346 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35245084 |

